Literature DB >> 2306413

Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.

G Alván1, L Helleday, A Lindholm, E Sanz, T Villén.   

Abstract

1. Frusemide was given intravenously at a dose of 5 mg kg-1 to five healthy volunteers and the diuresis was assessed by frequent spontaneous voiding over 5 h. Urinary volume and contents of sodium, chloride, potassium and frusemide were measured. 2. Diuretic response was evaluated using the sigmoid Emax model and non linear regression of diuresis vs frusemide excretion rate. The time courses of diuresis (pharmacological effect) and diuretic efficiency were constructed from the fitted parameters of the sigmoid Emax model. 3. The frusemide excretion rate associated with maximum efficiency was found, as predicted theoretically, to be less than the excretion rate associated with 50% of maximum effect in four of the five subjects in whom the slope factor was less than 2. 4. The effect over time is dependent both on the instantaneous drug effect but also on its pharmacokinetic properties and mode of administration. An intravenous bolus is the least efficient mode of administration while a controlled input producing a frusemide excretion at maximum efficiency should yield up to a 2.3 times higher diuretic response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306413      PMCID: PMC1380086          DOI: 10.1111/j.1365-2125.1990.tb03622.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Tubular chloride transport and the mode of action of some diuretics.

Authors:  M B Burg
Journal:  Kidney Int       Date:  1976-02       Impact factor: 10.612

2.  Determination of furosemide concentrations in plasma and urine using high-speed liquid chromatography.

Authors:  B Lindström
Journal:  J Chromatogr       Date:  1974-11-13

Review 3.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

4.  The time course of delivery of furosemide into urine: an independent determinant of overall response.

Authors:  S Kaojarern; B Day; D C Brater
Journal:  Kidney Int       Date:  1982-07       Impact factor: 10.612

5.  Renal tubular secretion and effects of furosemide.

Authors:  B Odlind; B Beermann
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

6.  Bumetanide and furosemide.

Authors:  D C Brater; P Chennavasin; B Day; A Burdette; S Anderson
Journal:  Clin Pharmacol Ther       Date:  1983-08       Impact factor: 6.875

7.  Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.

Authors:  G Alván; B Beermann; L Hjelte; M Lind; A Lindholm; B Strandvik
Journal:  Clin Pharmacol Ther       Date:  1988-10       Impact factor: 6.875

8.  Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.

Authors:  M M Hammarlund; B Odlind; L K Paalzow
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

  8 in total
  11 in total

1.  The influence of frusemide formulation on diuretic effect and efficiency.

Authors:  M Wakelkamp; A Blechert; M Eriksson; K Gjellan; C Graffner
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

2.  The validity of the sigmoid Emax model and efficiency concept in diuretic studies.

Authors:  G Alván; M Hammarlund-Udenaes; B Odlind
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

3.  Use of Emax model in diuretic studies.

Authors:  F H Noormohamed
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

4.  The influence of drug input rate on the development of tolerance to frusemide.

Authors:  M Wakelkamp; G Alván; H Scheinin; J Gabrielsson
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

5.  Comparison of four basic models of indirect pharmacodynamic responses.

Authors:  N L Dayneka; V Garg; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

Review 6.  The efficiency concept in pharmacodynamics.

Authors:  G Alván; G Paintaud; M Wakelkamp
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

7.  Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.

Authors:  G Alván; G Paintaud; S A Eckernäs; A Grahnén
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

8.  The influence of co-administered organic acids on the kinetics and dynamics of frusemide.

Authors:  D K Sommers; E C Meyer; J Moncrieff
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

9.  Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency.

Authors:  R W van Olden; J J van Meyel; P G Gerlag
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

10.  Goal-directed diuresis: A case - control study of continuous furosemide infusion in critically ill trauma patients.

Authors:  Daniel Dante Yeh; Gwendolyn M Van Der Wilden; Catrina Cropano; Yuchiao Chang; David R King; Marc De Moya; Peter Fagenholz; Haytham Kaafarani; Jarone Lee; George Velmahos
Journal:  J Emerg Trauma Shock       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.